Mccune-Albright Syndrome: A Case Report Associated with Pamidronate Therapy and Literature Review

Vakili, Rahim; Hashemian, Somayyeh; Jafarzadeh Esfehani, Reza; Zare Feizabadi, Azadeh

doi:10.22038/ijp.2019.36513.3181

Mccune-Albright Syndrome: A Case Report Associated with Pamidronate Therapy and Literature Review

Authors

Rahim Vakili ¹

Somayyeh Hashemian ²

Reza Jafarzadeh Esfehani ³

Azadeh Zare Feizabadi ⁴

¹ Department of Pediatric Endocrinology and Metabolism, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. AND Medical Genetic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

² Department of Pediatric Endocrinology and Metabolism, Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

³ Medical Genetic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

⁴ Department of Pediatric Endocrinology and Metabolism, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

10.22038/ijp.2019.36513.3181

Abstract

McCune-Albright Syndrome (MAS) is a rare sporadic disease characterized by bone fibrous dysplasia, Café au lait spots and a variable association of hyperfunction endocrine disorders. There is not any certain treatment available for this syndrome, and both physical and emotional disability in these patients is still a major concern for physicians. In present report we have described a 10- year-old girl, presented with precocious puberty, multiple Café au lait macules and fibrous dysplasia, successfully treated with pamidronate in a four-year follow-up period.

Keywords

Children

Iran

Fibrous dysplasia

McCune-Albright syndrome

Precocious puberty